Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bartek Lisowski

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 8, 2024
No body fits in the test tube - the case of transthyretinSeweryn Ulaszek, Barbara Wiśniowska, Bartek Lisowski
Data in Brief|April 15, 2024
Dataset of in vitro measured chemicals neurotoxicitySeweryn Ulaszek, Bartek Lisowski, Sebastian Polak
Pharmaceutics|March 28, 2026
Exploring Tafamidis Effects Through PBPK-QSP ModellingSeweryn Ulaszek, Bartek Lisowski, Barbara Wiśniowska, et al.
Entropy (Basel, Switzerland)|June 26, 2026
Hysteretic Conductance in Ion Channel GatingBartek Lisowski, Martin Bier, Bartłomiej Dybiec, et al.
Journal of Theoretical Biology|September 9, 2021
Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cellsVeronika Bernhauerová, Bartek Lisowski, Veronica V Rezelj, et al.
Scientific Reports|January 9, 2026
Phenomenological model of transthyretin stabilizationBartek Lisowski, Seweryn Ulaszek, Barbara Wiśniowska, et al.
Bulletin of Mathematical Biology|May 23, 2026
In Vitro Analysis and Dynamic Modeling of SARS-CoV-2 Infection Inhibition by Sigma-1 Receptor Antagonist PB28Bartek Lisowski, Veronica V Rezelj, Marco Vignuzzi, et al.
Drug Discovery Today|August 4, 2023
3D printing combined with biopredictive dissolution and PBPK/PD modeling optimization and personalization of pharmacotherapy: Are we there yet?Gabriela Wyszogrodzka-Gaweł, Olha Shuklinova, Bartek Lisowski, et al.
Drug Discovery Today|June 9, 2026
Insight into human allogenic CAR-T therapy: an open-access datasetNatalia Obajtek, Bartek Lisowski, Seweryn Ulaszek, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 8, 2024
No body fits in the test tube - the case of transthyretinSeweryn Ulaszek, Barbara Wiśniowska, Bartek Lisowski
Data in Brief|April 15, 2024
Dataset of in vitro measured chemicals neurotoxicitySeweryn Ulaszek, Bartek Lisowski, Sebastian Polak
Pharmaceutics|March 28, 2026
Exploring Tafamidis Effects Through PBPK-QSP ModellingSeweryn Ulaszek, Bartek Lisowski, Barbara Wiśniowska, et al.
Entropy (Basel, Switzerland)|June 26, 2026
Hysteretic Conductance in Ion Channel GatingBartek Lisowski, Martin Bier, Bartłomiej Dybiec, et al.
Journal of Theoretical Biology|September 9, 2021
Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cellsVeronika Bernhauerová, Bartek Lisowski, Veronica V Rezelj, et al.
Scientific Reports|January 9, 2026
Phenomenological model of transthyretin stabilizationBartek Lisowski, Seweryn Ulaszek, Barbara Wiśniowska, et al.
Bulletin of Mathematical Biology|May 23, 2026
In Vitro Analysis and Dynamic Modeling of SARS-CoV-2 Infection Inhibition by Sigma-1 Receptor Antagonist PB28Bartek Lisowski, Veronica V Rezelj, Marco Vignuzzi, et al.
Drug Discovery Today|August 4, 2023
3D printing combined with biopredictive dissolution and PBPK/PD modeling optimization and personalization of pharmacotherapy: Are we there yet?Gabriela Wyszogrodzka-Gaweł, Olha Shuklinova, Bartek Lisowski, et al.
Drug Discovery Today|June 9, 2026
Insight into human allogenic CAR-T therapy: an open-access datasetNatalia Obajtek, Bartek Lisowski, Seweryn Ulaszek, et al.
Pageof 1